coronavirus [cov]

This episode discusses five MMWR reports. First, a new CDC study shows that updated COVID-19 vaccines protect against symptomatic illness, including infections caused by the JN.1 variant. Second, Neptune's Fix, a flavored tianeptine elixir sold in gas stations, convenience stores, and online, is associated with serious clinical outcomes in 17 patients in New Jersey. Third, acute flaccid myelitis, or AFM, remained low in the U.S. between 2019 and 2022 despite increased circulation of EV-D68, an enterovirus previously connected to an increase in AFM cases. Fourth, Peru reported its largest dengue outbreak in 2023.

This episode discusses four MMWR reports. First, when trying to understand who gets diabetes and heart disease, looking at traditional categories of race and ethnicity doesn't tell the whole story. Second, antivirals, which are known to reduce the risk of severe COVID-19, are underused. Third, deaths among U.S. citizens who had cosmetic surgery in the Dominican Republic were mostly due to preventable conditions. Finally, poor infection control at a South Florida cosmetic surgery clinic most likely led to infections in nine states.

This episode discusses four MMWR reports. First, the percentage of adults reporting long COVID has decreased. However, 1 in 4 with long COVID reported significant impact to daily activities. Next, patients on dialysis had higher rates of SARS-CoV-2 infection and associated death compared to the general U.S. population during the Delta and early Omicron waves. Finally, tofu is identified as the source of a Salmonella outbreak in Ontario, Canada.

CDC Director Dr. Rochelle Walensky answers your questions about flu vaccines and the steps we can take to fight flu this season.

CDC Director, Dr. Rochelle Walensky, provides an update on COVID-19 vaccines that are now available to every American aged 12 and older who has received their primary series.

This episode discusses five MMWR reports. The first report highlights updated CDC guidance for the prevention of severe COVID-19 illness. The second report looks at post-COVID conditions in children. The third report examines hepatitis C treatment among insured adults in the United States. And the last two reports highlight the characteristics of U.S. monkeypox cases and provide interim guidance for the prevention and treatment of monkeypox in people with advanced HIV infection.

This episode discusses five MMWR reports The first two reports provide insights on acute hepatitis of unknown causes in children. The third report describes extreme heat exposure in Maricopa and Yuma Counties, Arizona. The fourth report examines COVID-19 death risk among long-term care facility residents. And the last report highlights COVID-19 cases and hospitalizations among Medicare beneficiaries with and without disabilities.

This episode discusses three MMWR reports. The first report examines ventilation improvement strategies in K-12 public schools. The second report describes racial and ethnic disparities in COVID-19 vaccination coverage. And the last report highlights the characteristics of adults evaluated for substance use and treatment planning.

This episode discusses three MMWR reports. The first report examines CDC's emergency response to a multistate monkeypox outbreak. The second report describes COVID-19 cases, hospitalizations, and deaths among Alaska Native people. And the last report highlights pediatric melatonin poisonings in the United States over the last decade.

This episode discusses four MMWR reports. The first report examines ACIP's recommendation for use of the JYNNEOS vaccine in people aged 18 years and older at risk for occupational exposure to orthopoxviruses such as monkeypox. The second report describes post-COVID conditions among adult COVID-19 survivors aged 18 years and older. The third report highlights barriers to and disparities in access to health care among adults aged 18 years and older with epilepsy. And the last report looks at seizure- or epilepsy-related emergency department visits before and during the COVID-19 pandemic.

This episode discusses three MMWR reports. The first report highlights COVID-19 death rates and vaccine coverage in Hong Kong during the ongoing Omicron COVID-19 outbreak. The second report examines 10 people infected with the Omicron variant within 90 days of being infected with Delta. And the last report looks at the effectiveness of mRNA vaccination after previous infection in preventing COVID-19-associated hospitalization with a reinfection.

This episode discusses nine MMWR reports. The first report looks at the effectiveness of mRNA COVID-19 vaccination among pregnant people against hospitalizations in infants younger than 6 months. The second report examines hospitalizations of children and teens with confirmed COVID-19. The next two reports look at changes in pediatric emergency department visits before and during the COVID-19 pandemic. The fifth report looks at safety monitoring of COVID-19 booster doses among adults. The sixth report examines waning effectiveness of two-dose and three-dose mRNA vaccines against emergency department and urgent care visits and hospitalizations during periods of Delta and Omicron predominance. The seventh report describes household spread of the Omicron variant. And the last two reports highlight the importance of following CDC's recommendations for wearing a well-fitting mask for 10 full days after showing symptoms or testing positive.

This episode discusses five MMWR reports. The first report looks at the effectiveness of masks in indoor settings for the prevention of COVID-19. The next report looks at the clinical characteristics and outcomes of adults hospitalized with COVID-19 during Omicron and Delta predominance. The third report examines COVID-19 infection and hospitalizations by vaccination status before and during Omicron. The fourth report describes vaccination coverage and vaccine confidence by sexual orientation and gender identity. And the last report looks at COVID-19 vaccination among New York adults living with diagnosed HIV.

This episode discusses two MMWR reports. The first report looks at trends in disease severity and health care utilization during the early Omicron variant period. And the second report looks at the effectiveness of a third dose of an mRNA vaccine in preventing COVID-19 hospitalization among adults with and without weakened immune systems.

This episode discusses six MMWR reports. The first report looks at racial and ethnic disparities in receipt of monoclonal antibodies for the treatment of COVID-19. The next three reports examine the protection provided by COVID-19 vaccines, including booster doses, during periods of Delta and Omicron variant emergence. The fifth report examines updated ACIP guidance for the use of Johnson & Johnson's Janssen COVID-19 vaccine. And the last report looks at early evidence of the Omicron variant in community wastewater.

This episode discusses four MMWR reports. The first report looks at the effectiveness of the Pfizer-BioNTech vaccine against multisystem inflammatory syndrome in children ages 12-17 years. The next report looks at the risk for newly diagnosed diabetes after COVID-19 infection among children. The third report examines COVID-19 vaccination during pregnancy and its association with preterm or small-for-gestational-age at birth. And the last report describes severe COVID-19 outcomes among people ages 18 years and older who have completed their primary vaccination series.

This episode discusses four MMWR reports. This first report looks at an Omicron variant cluster among a single household in Nebraska. The next report looks at vaccine safety in children ages 5-11 years. The third report examines the effectiveness of the Pfizer-BioNTech vaccine in preventing infection among adolescents ages 12-17 years. And the last report describes the characteristics and clinical outcomes in children and adolescents hospitalized with COVID-19.

This episode discusses five MMWR reports. This first report looks at the impact of a health care provider recommendation on vaccination status and attitudes among adults. The next two reports explore a testing strategy among k-12 schools in Los Angeles County, California and Lake County, Illinois. And the last two describe cases of a rare fungal infection reported by clinicians in Honduras and Arkansas during surges in Delta variant cases.

This episode discusses four MMWR reports. This first report looks at the U.S. response to the Omicron variant. The second highlights receipt of booster doses among adults ages 65 years and older. The third looks at the effectiveness of Pfizer-BioNTech and Moderna mRNA vaccines in preventing COVID-19-associated hospitalizations among older veterans. And the fourth report highlights vaccination rates among people experiencing homelessness.

This episode discusses six MMWR reports. The first two emphasize the risks associated with COVID-19 during pregnancy. The third report looks at infection rates, hospitalizations, and deaths among members of a large heath system. The fourth looks at health care access and use among adults with diabetes during COVID-19. The fifth report explores the impact surges in COVID-19 cases have on hospital systems. And the sixth report looks at the use of digital notification to provide timely outreach to people with COVID-19.